News
Robust Investment in Greater Philadelphia Region’s Cell and Gene Therapy Sector Continued in the First Quarter of 2021
Among the life sciences deals for the first quarter of 2021 were nine transactions in the cell and gene therapy space totaling more than $980 million.
Letter to the Editor: Invest in Cell and Gene Therapy
CEO Council for Growth's Executive Director Claire Greenwood submitted this letter to the editor in The Philadelphia Inquirer to emphasize the importance of investing in this sector to support the growth of our region.
Discovery, Accessibility and Affordability: Three Reasons to Join the Thousands of Cell & Gene Therapy Employees Already Working in Greater Philadelphia
For the nearly 5,000 employees working cell & gene therapy who call Philadelphia home, it has proven to be the best of both worlds with attributes that satisfy both your personal and professional life.
Philadelphia’s Talent Pipeline Collaborative Readies Region For Cell And Gene Therapy Job Growth
Claire Greenwood, Executive Director, CEO Council for Growth, and Patricia Day, Manager, Leadership Engagement, the Chamber of Commerce for Greater Philadelphia elaborate on the creation of the Life Science Talent Pipeline Collaborative in an op-ed originally published at CellandGene.com.
Big4Bio Philadelphia 2021 Outlook
The critically important work of the life sciences industry globally has been front and center as health care providers, researchers, manufacturers and distributors collaborate to respond to the coronavirus pandemic.